InflaRx NV (MEX:IFRXN) Total Liabilities: MXN416.61 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:IFRXN InflaRx NV MEX:IFRXN
35 GF Score
Price MXN22.00
! 2 Warning Signs
View Full Analysis

What is InflaRx NV Total Liabilities?

InflaRx NV MEX:IFRXN 35 Total Liabilities is MXN416.61 Mil as of Jun. 2026. GuruFocus rates MEX:IFRXN with a GF Score™ of 35/100. The stock has 2 warning signs investors should review.

InflaRx NV's Total Liabilities for the quarter that ended in Jun. 2026 was MXN416.61 Mil.

InflaRx NV's quarterly Total Liabilities declined from Dec. 2025 (MXN288.01 Mil) to Mar. 2026 (MXN250.17 Mil) but then increased from Mar. 2026 (MXN250.17 Mil) to Jun. 2026 (MXN416.61 Mil).

InflaRx NV's annual Total Liabilities declined from Dec. 2023 (MXN326.29 Mil) to Dec. 2024 (MXN318.89 Mil) and declined from Dec. 2024 (MXN318.89 Mil) to Dec. 2025 (MXN288.01 Mil).

InflaRx NV Total Liabilities Historical Data

* Premium members only.

The historical data trend for InflaRx NV's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InflaRx NV Total Liabilities Chart

InflaRx NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 460.30 290.17 326.29 318.89 288.01

InflaRx NV Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 356.13 426.09 288.01 250.17 416.61
MEX:IFRXN
35GF Score
InflaRx NV MEX:IFRXN
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

InflaRx NV Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

InflaRx NV's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=273.712+(13.515+0.78000000000002
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=288.01

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=1164.172-876.186
=287.99

InflaRx NV's Total Liabilities for the quarter that ended in Jun. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=404.584+(11.257+0.76400000000002
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=416.61

Total Liabilities=Total Assets (Q: Jun. 2026 )-Total Equity (Q: Jun. 2026 )
=3355.254-2938.669
=416.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of MXN416.61 Mil mean?
InflaRx NV (MEX:IFRXN) has a Total Liabilities of MXN416.61 Mil as of Jun. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for InflaRx NV and its competitors.
Is InflaRx NV's Total Liabilities too high?
InflaRx NV's current Total Liabilities is MXN416.61 Mil. Overall, InflaRx NV has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does InflaRx NV's Total Liabilities compare to VRXA and TTRX?
InflaRx NV's Total Liabilities of MXN416.61 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for InflaRx NV and its competitors. InflaRx NV's current Total Liabilities is MXN416.61 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InflaRx NV stock overvalued right now?
InflaRx NV (MEX:IFRXN) has a current Total Liabilities of MXN416.61 Mil. The current Total Liabilities is MXN416.61 Mil. InflaRx NV's overall GF Score™ is 35/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For InflaRx NV (MEX:IFRXN), the current Total Liabilities is MXN416.61 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

InflaRx NV Business Description

Other Exchanges IFRX:USAIF0:Germany
Address Winzerlaer Strasse 2, Jena, DEU, 07745
InflaRx NV is a biopharmaceutical company applying proprietary technologies to discover, develop and commercialize potent and specific inhibitors of the complement activation factor known as C5a and its receptor C5aR. With its therapeutic product candidates, vilobelimab and izicopan, the company targets C5a and its receptor C5aR to selectively inhibit the powerful inflammatory response observed in a wide variety of autoimmune and other inflammatory diseases elicited through C5a/C5aR activation. Its product candidate, GOHIBIC (vilobelimab), is a novel intravenously delivered anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
35GF Score

Get the complete analysis for MEX:IFRXN

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN22.00
Price